ArticleBlood neoplasia2025

Loss of p53 impairs death receptor expression and confers resistance to CD19 CAR T-cell therapy in BCP-ALL.

Willem P J Cox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.